Literature DB >> 28028783

Primary mesenteric neuroendocrine tumor that changed its internal composition from cystic to solid: a case report.

Akira Yasuda1, Hidehiko Kitagami2, Yasuhiro Kondo1, Keisuke Nonoyama1, Kaori Watanabe1, Shiro Fujihata1, Hirotaka Miyai1, Minoru Yamamoto1, Yasunobu Shimizu1, Moritsugu Tanaka1.   

Abstract

Mesenteric neuroendocrine tumors are usually metastases originating from the small intestine; however, primary mesenteric cases are rare. We present an interesting case of a mesenteric neuroendocrine tumor that changed its internal composition from cystic to solid. A 72-year-old male visited our hospital because of epigastralgia 4 years earlier. A 25-mm tumor was recognized around the terminal duodenum on computed tomography and magnetic resonance imaging, and was diagnosed as a cystic lesion. Over the following 2 years, the tumor grew to 40 mm and its internal composition changed from cystic to solid. The lesion showed positive findings on fluorodeoxyglucose positron emission tomography. Upon laparotomy, a solid tumor was detected in the mesentery of the jejunum near the ligament of Treitz. The tumor was extracted without intestinal resection and was diagnosed as a low-grade neuroendocrine tumor after histopathological and immunohistochemical examination. One year has passed since the operation, and there has been no recurrence.

Entities:  

Keywords:  Cystic tumor; FDG-PET; Mesentery; Neuroendocrine tumor

Mesh:

Substances:

Year:  2016        PMID: 28028783     DOI: 10.1007/s12328-016-0695-y

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  10 in total

1.  Carcinoid tumors of the abdomen: CT features.

Authors:  J P Pelage; P Soyer; M Boudiaf; I Brocheriou-Spelle; A C Dufresne; J Coumbaras; R Rymer
Journal:  Abdom Imaging       Date:  1999 May-Jun

Review 2.  Current status of gastrointestinal carcinoids.

Authors:  Irvin M Modlin; Mark Kidd; Igor Latich; Michelle N Zikusoka; Michael D Shapiro
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

3.  Cystic endocrine tumors of the pancreas: clinical, radiologic, and histopathologic features in 13 cases.

Authors:  B Ligneau; C Lombard-Bohas; C Partensky; P J Valette; A Calender; J Dumortier; G Gouysse; J Boulez; B Napoleon; F Berger; J A Chayvialle; J Y Scoazec
Journal:  Am J Surg Pathol       Date:  2001-06       Impact factor: 6.394

Review 4.  Mesenteric neoplasms: CT appearances of primary and secondary tumors and differential diagnosis.

Authors:  Sheila Sheth; Karen M Horton; Melissa R Garland; Elliot K Fishman
Journal:  Radiographics       Date:  2003 Mar-Apr       Impact factor: 5.333

5.  Predictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors.

Authors:  Etienne Garin; Florence Le Jeune; Anne Devillers; Marc Cuggia; Anne-Sophie de Lajarte-Thirouard; Catherine Bouriel; Eveline Boucher; Jean-Luc Raoul
Journal:  J Nucl Med       Date:  2009-05-14       Impact factor: 10.057

6.  Diagnostic value of (18)F-fluorodeoxyglucose positron emission tomography for pancreatic neuroendocrine tumors with reference to the World Health Organization classification.

Authors:  Toshihiko Masui; Ryuichiro Doi; Tatsuo Ito; Kazuhiro Kami; Kohei Ogawa; Daisuke Harada; Shinji Uemoto
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

7.  Primary carcinoid tumor of the mesentery.

Authors:  D E Barnardo; M Stavrou; R Bourne; W V Bogomoletz
Journal:  Hum Pathol       Date:  1984-08       Impact factor: 3.466

8.  Clinical validation of the gastrointestinal NET grading system: Ki67 index criteria of the WHO 2010 classification is appropriate to predict metastasis or recurrence.

Authors:  Takeshi Yamaguchi; Takahiro Fujimori; Shigeki Tomita; Kazuhito Ichikawa; Hiroyuki Mitomi; Kazuya Ohno; Yosuke Shida; Hiroyuki Kato
Journal:  Diagn Pathol       Date:  2013-04-22       Impact factor: 2.644

9.  Lesion-based analysis of (18)F-FDG uptake and (111)In-Pentetreotide uptake by neuroendocrine tumors.

Authors:  Kazuo Kubota; Momoko Okasaki; Ryogo Minamimoto; Yoko Miyata; Miyako Morooka; Kazuhiko Nakajima; Takashi Sato
Journal:  Ann Nucl Med       Date:  2014-09-02       Impact factor: 2.668

10.  Survival Analyses for Patients With Surgically Resected Pancreatic Neuroendocrine Tumors by World Health Organization 2010 Grading Classifications and American Joint Committee on Cancer 2010 Staging Systems.

Authors:  Min Yang; Neng-Wen Ke; Yi Zhang; Lin Zeng; Chun-Lu Tan; Hao Zhang; Gang Mai; Bo-le Tian; Xu-Bao Liu
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  10 in total
  2 in total

Review 1.  Imaging spectrum of mesenteric masses.

Authors:  Radwan Diab; Mayur Virarkar; Mohammed Saleh; Sherif Elsheif; Sanaz Javadi; Priya Bhosale; Silvana Faria
Journal:  Abdom Radiol (NY)       Date:  2020-11

2.  Primary grade 2 neuroendocrine tumor of the ileal mesentery: a case report.

Authors:  Shigemi Morishita; Shinichi Yoshida; Yasufumi Kamatani; Shinya Suzuhigashi; Masaki Kitou; Takuma Nasu
Journal:  Surg Case Rep       Date:  2022-08-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.